Healthcare Economist was once again named one of the Top 10 Health Economics Blogs and Websites in 2025 (#4) by Feedspot. Feedspot also named this blog as a top 50 Best Public Health Blogs and Websites in 2025 (#13). Exciting to keep the blogging going into the future!
The Trump administration is not finalizing a Biden-era provision that would expand coverage of anti-obesity drugs under Medicare and Medicaid, which has disappointed some healthcare leaders. The post Health Execs Criticize Trump Administration for Not Expanding Coverage of Obesity Drugs appeared first on MedCity News.
Bristol Myers Squibb is licensing global rights to a Philochem program in development for both diagnostic imaging and targeted treatment of prostate cancer. It follows the pharma giant’s entry into radiopharmaceuticals via the $4.1 billion acquisition of RayzeBio last year. The post Bristol Myers Squibb Is Paying $350M to Expand Its Reach in Radiopharmaceuticals to…
The structure of Atalanta Therapeutics’ RNA interference drugs enables them to distribute broadly and deeply into brain tissue. Lead programs for Huntington’s disease and a rare inherited form epilepsy are on track to enter the clinic this year. The post RNAi Biotech Atalanta Unveils $97M to Reach the Clinic in Two Rare Neuro Diseases appeared…
There are a number of important ways AI will impact patients, providers and pharmacies in the coming year. They break down into three key areas. The post How AI Will Change the ePrescribing Experience for Patients, Providers and Pharmacies appeared first on MedCity News.
AstraZeneca’s deal with CSPC Pharmaceutical Group includes a Phase 1-ready obesity drug that hits the same targets as Eli Lilly’s obesity drug Zepbound, but with monthly dosing. The new collaboration builds on an existing drug R&D relationship between the two companies. The post AstraZeneca Beefs Up in Metabolic Disease, Paying $1.2B to Partner on CSPC…
In southern Colorado’s San Luis Valley, clouds billow above the towering mountains of the Sangre de Cristo range. A chorus of blackbirds whistle as they flit among the reeds of a wildlife refuge. Big, circular fields of crops, interspersed with native shrubs, give it a feel of bucolic quiet. But amid the stark beauty in…
KFF Health News chief Washington correspondent Julie Rovner discussed Medicaid cuts in the House budget bill on CBS News on May 22. Click here to watch Rovner on CBS News. Céline Gounder, KFF Health News’ editor-at-large for public health, discussed weight loss drugs and covid-19 vaccines on CBS’ “CBS Mornings” on May 22 and May…
Nearly 1 in 4 Medicaid enrollees are eligible for the program because they are ages 65 and older or have a disability, and they have higher per-enrollee costs than other enrollees. Proposals to limit federal spending on Medicaid may create incentives for states to drop or reduce their eligibility or coverage for seniors and people…
